You are here

Aveo Oncology

Aveo spins a silver lining in failed trial of kidney cancer drug Fotivda

Fierce Pharma

Thu, 07/18/24 - 11:06 pm

Bristol Myers Squibb

Korean firm LG Chem buying AVEO Oncology for $566M

CP WIre

Tue, 10/18/22 - 01:57 pm

Korean firm LG Chem buying AVEO Oncology for $566M

Tue, 10/18/22 - 01:55 pm

Aveo Oncology's Fotivda receives FDA approval

Pharma Live

Thu, 03/11/21 - 10:32 am

metastatic renal cell carcinoma

Aveo regains full rights to ficlatuzumab as partner splits before phase 3

Fierce Biotech

Tue, 09/8/20 - 10:39 pm

clinical trials

Aveo gives up on ficlatuzumab in acute myeloid leukemia, citing COVID-19

Fierce Biotech

Mon, 03/30/20 - 10:33 am

clinical trials

FDA tells Aveo no, again, for tivozanib as biotech tries to find yet another path forward

Fierce Biotech

Mon, 11/4/19 - 10:20 am

Renal Cell Carcinoma Space in Focus: Some Key Developments

Yahoo/Zacks.com

Sat, 09/14/19 - 11:18 am

renal cell carcinoma

After falling short on prelim OS data, EMA tells Aveo it wants to see something better on its long suffering tivo this summer — or else

Endpoints

Wed, 04/3/19 - 10:03 am

Aveo Oncology Stock Spikes on Rumors of AstraZeneca Acquisition

BioSpace

Thu, 03/28/19 - 12:06 pm

Aveo stock plunges after delay in FDA approval submission for cancer drug

Bizjournals

Fri, 02/1/19 - 12:16 am

advanced renal cell carcinoma

AZ begins liver cancer immunotherapy tie-up with AVEO

Pharmaforum

Thu, 12/13/18 - 10:29 am

cancer immunotherapy

hepatocellular carcinoma

Here's Why AVEO Oncology Rose as Much as 15% Today

Motley Fool

Wed, 07/19/17 - 07:52 pm

Here's Why AVEO Oncology Fell as Much as 12.7% Today

Motley Fool

Tue, 07/11/17 - 11:51 pm

renal cell carcinoma

Aveo's tivozanib finally moving forward after 4-year delay

BioPharma Dive

Sat, 02/25/17 - 01:56 pm

Aveo’s kidney cancer drug submitted for approval in Europe

Bizjournals.com

Tue, 03/1/16 - 10:58 pm

Novartis bets on a slumping Aveo in a $326M cancer deal

Fierce Biotech

Mon, 08/17/15 - 10:13 am

Aveo endures yet another FDA setback

Fierce Biotech

Sat, 06/13/15 - 09:39 am

NRP-1 diagnostics

Tivozanib Is the Gift That Keeps On Giving For Aveo

24/7 Wall St

Thu, 06/4/15 - 08:14 pm

renal cell carcinoma

Aveo set to soar today on news of potential drug approval in Europe

Bizjournals.com

Thu, 06/4/15 - 11:29 am

Pages